PDE10A and Dystonia: The second dystonia-related candidate that we identified in our bioinformatic assessments was Pde10a, a cAMP- and cGMP-inactivating phosphodiesterase that is specifically expressed in striatal GABAergic medium spiny neurons (MSNs) and that regulates dopamine receptor signaling [22].